Latest news
Price to earnings forward of Aprea Therapeutics, Inc. – NASDAQ:APRE - TradingViewTradingView · Sun, 09 Aug 2026 04:52:58 GMTAprea Therapeutics Inc (APRE) Stock News Today - TradingKeyTradingKey · Sat, 08 Aug 2026 03:23:39 GMTAprea Therapeutics, Inc. (APRE) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 13:57:51 GMTAprea Therapeutics Inc (APRE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Thu, 06 Aug 2026 07:00:00 GMTAPRE Q2'26 Earnings: EPS estimate is (0.18) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:02:02 GMTAPRE Q1 2026 Earnings: Narrower-than-Expected Loss Beats Estimates, Shares Slide 2.36% - High Growth Earnings - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 07:32:06 GMTAprea Therapeutics Inc (APRE) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTAprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026 - The Manila TimesThe Manila Times · Thu, 30 Jul 2026 07:00:00 GMT